Berita Kesehatan
Blood eosinophil counts in COPD patients compared to controls
Senin, 24 Jun 2019 09:49:59

Umme KolsumThomas SouthworthNatalie JacksonDave Singh

European Respiratory Journal 2019; DOI: 10.1183/13993003.00633-2019

Extract

In patients with chronic obstructive pulmonary disease (COPD), blood eosinophil counts can predict the effects of inhaled corticosteroids (ICS) on exacerbation rates [1–4]. Blood eosinophil counts are now recommended by the Global initiative for the management of Obstructive Lung Disease (GOLD) as a biomarker to help guide ICS use in clinical practice [5].

Footnotes

This manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article.

Conflict of interest: Dr. Kolsum has nothing to disclose.

Conflict of interest: Dr. Southworth reports I am an employee of The Medicines Evaluation Unit.

Conflict of interest: Dr. Jackson has nothing to disclose.

Conflict of interest: Dr. Singh reports grants and personal fees from AstraZeneca, grants and personal fees from Boehringer Ingelheim, grants and personal fees from Chiesi, personal fees from Cipla, personal fees from Genentech, grants and personal fees from GlaxoSmithKline, grants and personal fees from Glenmark, grants and personal fees from Menarini, grants and personal fees from Mundipharma, grants and personal fees from Novartis, personal fees from Peptinnovate, grants and personal fees from Pfizer, grants and personal fees from Pulmatrix, grants and personal fees from Therevance, grants and personal fees from Verona, outside the submitted work.